Welcome to our dedicated page for Vystar SEC filings (Ticker: VYST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vystar Corporation (OTCQB: VYST) filings page on Stock Titan is intended to centralize access to the company’s regulatory disclosures and related documents. While no SEC filings are listed in the available data here, investors typically look to such filings for detailed information on areas that Vystar highlights in its public communications, including Vytex natural rubber latex operations, RxAir UV-C air purification products, Fluid Energy Conversion and Fluid Energy Solutions technologies, and its partner or investment activities around GoPaid.com and collectibles tokenization.
For a company like Vystar, formal SEC reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, can provide narrative and quantitative discussion of business segments, risk factors, intellectual property, and capital structure. Current reports on Form 8-K may disclose material events such as binding Letters of Intent, strategic partnerships, or significant legal outcomes, including litigation involving convertible notes that Vystar has discussed in its press releases.
In addition to core reports, investors often review proxy statements for information on governance and compensation, and any Form 4 insider transaction reports to understand trading by directors and officers, when such filings exist. Stock Titan’s platform is designed to pair these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language, highlight key sections, and help users quickly identify items related to Vystar’s technologies, intellectual property, and strategic initiatives.
As new VYST-related filings are made available through EDGAR, this page can serve as a starting point for reviewing the company’s formal regulatory history alongside its press releases and other public statements.
Vystar Corporation reported Q3 2025 results showing very limited sales and ongoing losses. Revenue was $20,385, led by air purification units of $14,812 (72.7% of sales). Gross profit was $15,365, offset by operating expenses of $262,341, resulting in an operating loss of $246,976 and a net loss of $271,387 (basic and diluted loss per share $0.01). For the nine months, revenue was $44,657 with a net loss of $1,236,593.
Liquidity remains strained: cash was $16,584, current liabilities totaled $6,725,826 against current assets of $390,602, and stockholders’ deficit was $(6,242,094). Management states there is substantial doubt about the company’s ability to continue as a going concern.
The balance sheet includes a related party term note (Blue Oar) with a carrying amount of approximately $750,000 and a related derivative liability of $356,142. Share-based compensation expense was $199,097 in Q3. Common shares outstanding were 22,485,017 as of November 12, 2025.
FAQ
What is the current stock price of Vystar (VYST)?
What is the market cap of Vystar (VYST)?
